Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25949255 | 0.87 | LMNA (0.37) | — | |
| SCHEMBL14895459 | 0.74 | HSD17B10 (0.39) | HSD17B10TDP1USP2 | |
| SCHEMBL8524164 | 0.73 | TDP1 (0.33) | TDP1 | |
| SCHEMBL27953891 | 0.70 | USP2 (0.50) | HSD17B10TDP1USP2 | |
| SCHEMBL23220483 | 0.68 | TDP1 (0.36) | TDP1 | |
| SCHEMBL14618765 | 0.68 | TDP1 (0.36) | TDP1 | |
| SCHEMBL14747616 | 0.68 | TDP1 (0.36) | TDP1 | |
| SCHEMBL23220490 | 0.68 | TDP1 (0.36) | TDP1 | |
| SCHEMBL21782825 | 0.68 | TDP1 (0.36) | TDP1 | |
| SCHEMBL18332860 | 0.68 | LMNA (0.34) | TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302041-A1 | Competitive Self-Blocking with Unlabeled Manocept Imaging Agents | SCOTT, JOHN KIM, JR. | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302041-A1 | Competitive Self-Blocking with Unlabeled Manocept Imaging Agents | MANBA, MAN2B2, MAN2B1 | HSD17B10 3941/4885TDP1 4838/4885USP2 3166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.